Insider Transactions in Q4 2022 at Macrogenics Inc (MGNX)
Insider Transaction List (Q4 2022)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 27
2022
|
Target N V Biotech > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
200,000
+2.19%
|
$1,000,000
$5.61 P/Share
|
|
Dec 23
2022
|
Target N V Biotech > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
200,000
+2.24%
|
$1,000,000
$5.88 P/Share
|
|
Nov 22
2022
|
Target N V Biotech > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
300,000
+3.4%
|
$1,500,000
$5.96 P/Share
|
|
Oct 28
2022
|
Eric Blasius Risser Chief Operating Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
8,500
+13.72%
|
$8,500
$1.51 P/Share
|
|
Oct 24
2022
|
Target N V Biotech > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
250,000
+2.95%
|
$1,000,000
$4.36 P/Share
|
|
Oct 21
2022
|
Target N V Biotech > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
250,000
+3.04%
|
$1,000,000
$4.63 P/Share
|
|
Oct 20
2022
|
Target N V Biotech > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
285,977
+3.57%
|
$1,143,908
$4.0 P/Share
|
|
Oct 19
2022
|
Target N V Biotech > 10% Shareholder |
BUY
Open market or private purchase
|
Direct |
168,422
+2.21%
|
$505,266
$3.7 P/Share
|